The U.S. Food and Drug Administration signed a letter of support May 30 for openly sharing data through efforts such as the Patient Safety Movement Foundation's Open Data Pledge, according to an announcement made June 27.
The FDA says open data engages patients in developing and evaluating medical devices, allows for the identification and prevention of adverse events and sheds light on the benefits and risks of healthcare technology.
Leaders in healthcare technology commit to openly sharing data when they sign the Patient Safety Movement's Open Data Pledge. Algorithms based on the data help reduce preventable patient harm and deaths.